A Study on the efficacy of neoadjuvant chemotherapy with carboplatin, docetaxel and bevacizumab in patients with non-squamous non-small cell lung cancer
Not Applicable
Recruiting
- Conditions
- on-Squamous Non-Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000008817
- Lead Sponsor
- ihon University School of Medicine Itabashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of severe drug allergy 2) Patients with uncontrollable complications 3) Patients with symptomatic Brain metastasis 4) History of hemoptysis ( >= 2.5mL) 5) History of continuous hemosputum 6) Patients with massive pleural and cardiac effusion 7) Patients with uncontrollable peptic ulcer 8) History of myocardial infarction or cerebral infarction 9) Current or previous history of GI perforation 10) Patients with therapeutic anticoagulopathy 11) Pregnancy, breast feeding and suspected pregnancy 12) Active concomitant malignancy 13) Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pathological complete resection rate
- Secondary Outcome Measures
Name Time Method Pathological response rate (pRR) Complete resection rate Relapse-free survival (RFS) Overall survival (OS) Safety